Cargando…
The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
Recently, the Blinding of Trial Statisticians research team, Iflaifel and colleagues, have produced detailed guidance regarding the blinding or unblinding of statisticians in clinical trials, based on substantial mixed-methods work. I wish to comment on the research findings. In particular, I argue...
Autor principal: | Parker, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494368/ https://www.ncbi.nlm.nih.gov/pubmed/37691093 http://dx.doi.org/10.1186/s13063-023-07623-3 |
Ejemplares similares
-
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
por: Hardy, John, et al.
Publicado: (2023) -
A response to Al et al. Trials 2023;24:233
por: Merz, Jon F.
Publicado: (2023) -
Natural unblinding of BCG vaccination trials
por: Szigeti, Reka, et al.
Publicado: (2021) -
Can a Y Chromosome Degenerate in an Evolutionary Instant? A Commentary on Fong et al. 2023
por: Charlesworth, Deborah, et al.
Publicado: (2023) -
Commentary by Gácsi et al. (2023) highlights general misconceptions within the field of dog domestication and dog–wolf comparisons
por: Hansen Wheat, Christina, et al.
Publicado: (2023)